Atlas Trials

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Clinical trial NCT00727831 · COMPLETED

Trial details

NCT number
NCT00727831
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chemotherapeutic Agent ToxicityLymphomaMucositisNeurotoxicity
Start date
2008-07-01
Primary completion
2011-07-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.